首页> 美国卫生研究院文献>Marine Drugs >Marine-Derived Macrocyclic Alkaloids (MDMAs): Chemical and Biological Diversity
【2h】

Marine-Derived Macrocyclic Alkaloids (MDMAs): Chemical and Biological Diversity

机译:海洋衍生的宏环生物碱(MDMAS):化学和生物多样性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The curiosity and attention that researchers have devoted to alkaloids are due to their bioactivities, structural diversity, and intriguing chemistry. Marine-derived macrocyclic alkaloids (MDMAs) are considered to be a potential source of drugs. Trabectedin, a tetrahydroisoquinoline derivative, has been approved for the treatment of metastatic soft tissue sarcoma and ovarian cancers. MDMAs displayed potent activities that enabled them to be used as anticancer, anti-invasion, antimalarial, antiplasmodial, and antimicrobial. This review presents the reported chemical structures, biological activities, and structure–activity relationships of macrocyclic alkaloids from marine organisms that have been published since their discovery until May 2020. This includes 204 compounds that are categorized under eight subclasses: pyrroles, quinolines, bis-quinolizidines, bis-1-oxaquinolizidines, 3-alkylpiperidines, manzamines, 3-alkyl pyridinium salts, and motuporamines.
机译:研究人员致力于生物碱的好奇心和关注是由于它们的生物活化,结构多样性和有趣的化学。海洋衍生的宏环生物碱(MDMAS)被认为是药物的潜在来源。已经批准了捕获四氢异喹啉衍生物,用于治疗转移性软组织肉瘤和卵巢癌。 MDMAS显示有效的活动,使其能够用作抗癌,抗侵袭,抗疟疾,抗癌症和抗菌剂。本综述介绍了自从其发现至2020年5月以来已发表的海洋生物中的宏环生物碱的报告的化学结构,生物活性和结构 - 活性关系。这包括204种化合物,该化合物在八个亚类中分类:胃肠杆菌,喹啉,双 - 喹诺氨酸,双-1-氧喹啉,3-烷基哌啶,甘三胺,3-烷基吡啶盐和蛋白质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号